Compare BioNano Genomics Inc (BNGO) vs iShares MSCI Japan ETF (EWJ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNano Genomics Inc vs iShares MSCI Japan ETF — how do they compare? BioNano Genomics Inc trades at $1.18 (market cap $13.66M), while iShares MSCI Japan ETF trades at $97.88. The key difference: iShares MSCI Japan ETF is trading nearer its 52-week high, BioNano Genomics Inc nearer its low. Which is the better fit depends on your goals.
| BNGO | EWJ | |
|---|---|---|
Market Cap | $13.66M | — |
Sector | Health | Broad Market / Factor |
52-Week High | $4.92 | $96.97 |
52-Week Low | $1.06 | $77.93 |
Enterprise Value | $16.26M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BNGO trades at $1.195, up 3.02% today, with a bullish technical signal from moving averages but a neutral oscillator stance. The company shows improving financial trends, with net losses narrowing to -$26.40M in 2025 from -$232M in 2023, and recent earnings beats. Revenue stabilized around $29M, while cash flow trends indicate reduced operational cash burn. Analyst sentiment is positive, with 57% buy ratings.
The outlook for BNGO hinges on sustaining revenue growth and achieving profitability, supported by strategic hires and debt retirement. Key risks include persistent negative margins and high cash burn. With a low P/S of 0.31, the stock offers value if execution improves, but investors face volatility from operational challenges and competitive pressures.
EWJ, the iShares MSCI Japan ETF, trades at $97.79, up 1.81% today, with a bullish technical signal driven by strong moving average alignment. The fund's performance is influenced by Japanese economic policies, including recent U.S.-Japan currency intervention and domestic stimulus efforts. Key resistance sits at $97, with support at $96. Recent news highlights focus on yen strength and its impact on export-heavy Japanese equities.
The outlook for EWJ is cautiously optimistic, supported by bullish technicals and potential economic tailwinds from Japanese fiscal policy. Risks include yen volatility, export sensitivity to currency moves, and broader Asian market turbulence. Investor sentiment is mixed, balancing policy support against inflation and growth concerns.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About BioNano Genomics Inc
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
Read more on BNGO →About iShares MSCI Japan ETF
EWJ tracks the MSCI Japan Index, providing broad exposure to over 180 large and mid-cap companies in Japan. It is the most established and liquid vehicle for accessing the Japanese equity market, featuring a diversified portfolio across industrials, consumer discretionary, and financial sectors.
Read more on EWJ →
